Increlex® 10 mg/ml solution for injection (mecasermin, recombinant human IGF-1): Temporary market shortage
2013.04.30
Active substance: mecasermin, recombinant human IGF-1
The company Ipsen Pharma GmbH is sending out information that the medicinal product Increlex® 10 mg/ml solution for injection will presumably be out of stock starting early August 2013. This shortage is due to manufacturing difficulties and the safety or efficacy of Increlex® already on the market is not affected.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN